Kenneth Grossmann, MD
This module covers the common adverse reactions noted in the prescribing information for currently approved immunotherapeutic cancer agents, as well as the warnings and precautions specific to those agents, any known drug interactions and contraindications or limitations of use.
See “Clinical Indications ” module to review the cancers these immunotherapeutic agents are approved to treat and recommended treatment algorithms.
Upon completion of this module, participants should be able to:
- Recognize the most common adverse reactions associated with the currently approved immunotherapeutic agents.
- Describe and understand the warnings and precautions associated with these agents.
- Understand which immunotherapeutic agents have known reactions with other drugs.
- Discuss the populations in which certain immunotherapy drugs are contraindicated.